实时人工智能视觉病理增强三维OCT扫描能否优化nAMD治疗决策?RAZORBILL研究原理与设计
RAZORBILL是一项观察性、多中心、多国、开放标签研究,旨在评估基于AI的分割算法通过自动定量测量液体和层结构来丰富三维视网膜OCT扫描,对新生血管性年龄相关性黄斑变性(nAMD)疾病活动度评估的影响。研究分两阶段:第一阶段在真实临床环境中收集数据;第二阶段采用整合交叉设计,由研究者对增强和原始OCT扫描分别评估疾病活动度,研究者作为自身对照。
要点
- RAZORBILL研究评估AI分割算法增强3D OCT对nAMD疾病活动度评估的影响。
- 研究采用整合交叉设计,研究者作为自身对照,比较增强与原始OCT扫描的评估结果。
- 研究分两阶段:真实世界临床数据收集和OCT enrichment分析。
核心结论
- RAZORBILL研究将揭示基于AI的临床决策支持工具在nAMD治疗中的价值,并明确其能否优化常规临床中的个体化治疗。
研究设计与样本
- RAZORBILL是一项观察性、多中心、多国、开放标签研究,包含两个阶段。
- 第一阶段为临床数据收集,采用观察性设计,不强制严格访视计划或治疗方案,以在真实临床环境中收集数据。
- 第二阶段为OCT enrichment分析,对去标识化的3D OCT扫描评估疾病活动度。
- 评估采用整合交叉设计,研究者作为自身对照,分别审阅增强分割结果(突出并定量病理液体体积)的扫描和原始(非增强)状态的扫描。
临床怎么用
- 研究结果将指导AI临床决策支持工具是否可应用于nAMD患者的临床治疗,并评估其能否优化常规临床中的个体化治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/RATIONALE: Artificial intelligence (AI)-based clinical decision support tools, being developed across multiple fields in medicine, need to be evaluated for their impact on the treatment and outcomes of patients as well as optimisation of the clinical workflow. The RAZORBILL study will investigate the impact of advanced AI segmentation algorithms on the disease activity assessment in patients with neovascular age-related macular degeneration (nAMD) by enriching three-dimensional (3D) retinal optical coherence tomography (OCT) scans with automated fluid and layer quantification measurements. METHODS: RAZORBILL is an observational, multicentre, multinational, open-label study, comprising two phases: (a) clinical data collection (phase I): an observational study design, which enforces neither strict visit schedule nor mandated treatment regimen was chosen as an appropriate design to collect data in a real-world clinical setting to enable evaluation in phase II and (b) OCT enrichment analysis (phase II): de-identified 3D OCT scans will be evaluated for disease activity. Within this evaluation, investigators will review the scans once enriched with segmentation results (i.e., highlighted and quantified pathological fluid volumes) and once in its original (i.e., non-enriched) state. This review will be performed using an integrated crossover design, where investigators are used as their own controls allowing the analysis to account for differences in expertise and individual disease activity definitions. CONCLUSIONS: In order to apply novel AI tools to routine clinical care, their benefit as well as operational feasibility need to be carefully investigated. RAZORBILL will inform on the value of AI-based clinical decision support tools. It will clarify if these can be implemented in clinical treatment of patients with nAMD and whether it allows for optimisation of individualised treatment in routine clinical care.
引用
- Holz FG, Abreu-Gonzalez R, Bandello F, et al. Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL study. Br J Ophthalmol. 2021. PMID: 34362776. doi:10.1136/bjophthalmol-2021-319211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。